EDTA-mediated inhibition of DNases protects circulating cell-free DNA from ex vivo degradation in blood samples

The exogenous and endogenous DNases are more active in serum, the anticoagulant EDTA indirectly inhibits blood DNases, and consequently ccfDNA is protected from the blood's DNase preanalytical impact in EDTA-plasma.